Physician profile
John D Olson
NPI 1326340225
$1,584.25
in general payments reported to CMS, 2019-2025
17 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $280 · 2023: $429 · 2024: $383 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.93 | 2021-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $281.32 | 2021-2024 | |
| Amgen INC. | $146.08 | 2023-2025 | Otezla, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $109.38 | 2022-2024 | Steglatro, Belsomra, Verquvo |
| Lilly USA, LLC | $103.61 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $101.25 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.01 | 2024-2025 | |
| Glaxosmithkline, LLC. | $87.94 | 2021-2024 | Arexvy |
| Dexcom, INC. | $77.05 | 2021-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $72.16 | 2024 | Voquezna |
| Pfizer INC. | $52.56 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $42.24 | 2024-2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.65 | 2022-2023 | |
| Astellas Pharma US INC | $30.67 | 2025 | Veozah |
| Phadia US INC. | $24.29 | 2023 | Immunocap |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $16.80 | 2025 | Yupelri |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.